Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
NVIDIA
NVDA
|
$7.3B |
| 2 |
Eli Lilly
LLY
|
$3.9B |
| 3 |
Starbucks
SBUX
|
$3.78B |
| 4 |
Arista Networks
ANET
|
$1.4B |
| 5 |
Dominion Energy
D
|
$1.23B |
Top Sells
| 1 |
UnitedHealth
UNH
|
$4.7B |
| 2 |
Gilead Sciences
GILD
|
$2.61B |
| 3 |
Salesforce
CRM
|
$2.56B |
| 4 |
GE HealthCare
GEHC
|
$2.31B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$1.77B |
Sector Composition
| 1 | Technology | 29.16% |
| 2 | Consumer Discretionary | 13.59% |
| 3 | Healthcare | 12.72% |
| 4 | Industrials | 11.43% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
iShares Core S&P 500 ETF
IVV
$662B
| $320K | ﹤0.01% | +518 | New | +$320K |
|
427
iShares Russell 1000 Growth ETF
IWF
$116B
| $277K | ﹤0.01% | 658 +17 | +3% | +$7.16K |
|
428
GE Vernova
GEV
$167B
| $228K | ﹤0.01% | 438 -715,002 | -100% | -$372M |
|
429
AvidXchange
AVDX
$2.06B
| – | – | -164,986 | Closed | -$1.4M |
|
430
KE Holdings
BEKE
$20.8B
| – | – | -18,172,622 | Closed | -$365M |
|
431
Bristol-Myers Squibb
BMY
$96B
| – | – | -1,150,000 | Closed | -$70.1M |
|
|
BPMC
432
DELISTED
Blueprint Medicines
BPMC
| – | – | -311,137 | Closed | -$27.5M |
|
433
CCC Intelligent Solutions
CCCS
$6.45B
| – | – | -719,325 | Closed | -$6.5M |
|
434
Church & Dwight Co
CHD
$22.7B
| – | – | -1,247,188 | Closed | -$137M |
|
435
Charter Communications
CHTR
$36.3B
| – | – | -1,626,990 | Closed | -$600M |
|
436
Crocs
CROX
$4.76B
| – | – | -107,501 | Closed | -$11.4M |
|
437
CubeSmart
CUBE
$9.33B
| – | – | -607,296 | Closed | -$25.9M |
|
438
Delta Air Lines
DAL
$40.3B
| – | – | -631,987 | Closed | -$27.6M |
|
439
Dine Brands
DIN
$368M
| – | – | -999,093 | Closed | -$23.2M |
|
440
General Motors
GM
$55.8B
| – | – | -2,624,075 | Closed | -$123M |
|
441
Grocery Outlet
GO
$1.78B
| – | – | -3,559,597 | Closed | -$49.8M |
|
442
Structure Therapeutics
GPCR
$1.11B
| – | – | -2,164,145 | Closed | -$37.5M |
|
443
GitLab
GTLB
$7.93B
| – | – | -2,050,027 | Closed | -$96.4M |
|
444
Hanesbrands
HBI
$2.23B
| – | – | -3,420,374 | Closed | -$19.7M |
|
445
Integra LifeSciences
IART
$1.18B
| – | – | -825,742 | Closed | -$18.2M |
|
446
Kraft Heinz
KHC
$33.1B
| – | – | -694,940 | Closed | -$21.1M |
|
447
Lands' End
LE
$438M
| – | – | -2,100,000 | Closed | -$21.4M |
|
448
Levi Strauss
LEVI
$8.85B
| – | – | -6,625,378 | Closed | -$103M |
|
449
LivaNova
LIVN
$3.08B
| – | – | -2,078,430 | Closed | -$81.6M |
|
450
Marriott International Class A Common Stock
MAR
$72.7B
| – | – | -361,603 | Closed | -$86.1M |
|